Rena Cooper-Kazaz. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Anticonvulsants/therapeutic useAntidepressive Agents, Second-Generation/therapeutic useCircadian RhythmCyclohexanols/therapeutic useDrug Therapy, CombinationFeeding Behavior/drug effectsFeeding and Eating Disorders/drug therapyFeeding and Eating Disorders/psychologyFemaleFructose/analogs & derivativesFructose/therapeutic useHumansMiddle AgedSleep Initiation and Maintenance Disorders/drug therapySleep Initiation and Maintenance Disorders/psychologyTopiramateVenlafaxine Hydrochloride
Substances： See more » AnticonvulsantsAntidepressive Agents, Second-GenerationCyclohexanolsTopiramateFructoseVenlafaxine Hydrochloride
Year: 2012 PMID： 22217954 DOI： 10.1097/JCP.0b013e31823f9051
Source DB: PubMed Journal: J Clin Psychopharmacol ISSN： 0271-0749 Impact factor: 3.153